Daré Bioscience Announces Exclusive Development and Option Agreement with Orbis Biosciences for Long-acting Injectable Contraceptive 

World News: . []

SAN DIEGO March 12 2018 GLOBE NEWSWIRE -- NASDAQDARE a clinical-stage womens biopharmaceutical company, today announced that it has entered into an agreement with Orbis Biosciences Inc for the development of an injectable etonogestr el cont...

More news and information about Dare Bioscience, Inc.

Published By:

Globe Newswire: 12:00 GMT Monday 12th March 2018

Published: .

Search for other references to "bioscience" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us